> Research summary—not medical advice. This page synthesizes published research on a mechanism-level intervention. It is not a clinical recommendation.

Consult a qualified healthcare provider before making any changes to diet, supplementation, or treatment.

Contents1. Overview2. Mechanism of Action3. Dosage and Administration4. Monitoring5. Contraindications and Risks6. Connections

Overview#

Selenium supplementation provides the essential trace element required for synthesis of 25 human selenoproteins, including the glutathione peroxidase family (GPX1-4), thioredoxin reductases (TrxR1-3), and iodothyronine deiodinases (DIO1-3). The thyroid gland has the highest selenium concentration per gram of any human organ, making thyroid autoimmune conditions the primary indication.

> Clinical disclaimer: Selenium has a narrow therapeutic window. The difference between therapeutic dose (200 ug/day) and toxicity threshold (400 ug/day) is only 2x. All supplementation should include baseline and follow-up serum selenium monitoring.

Mechanism of Action#

Selenium is incorporated as selenocysteine (the "21st amino acid") into selenoproteins via a unique UGA codon recoding mechanism. Key functional classes.

GPX1-4: Reduce hydrogen peroxide and lipid hydroperoxides, protecting cell membranes from oxidative damage. TrxR1-3: Regenerate thioredoxin, maintaining intracellular redox balance and regulating NF-kB signaling. DIO1-3: Catalyze T4→T3 conversion (DIO1/2) and T4/T3 inactivation (DIO3), governing thyroid hormone metabolism.

In selenium deficiency, these enzymes lose function in a hierarchical manner—brain and endocrine tissues are protected last, but thyroid GPX activity drops early, increasing vulnerability to hydrogen-peroxide-mediated autoimmune attack.

Dosage and Administration#

ParameterRecommendation
FormSelenomethionine (best absorbed, most studied in RCTs)
Therapeutic dose200 ug/day for autoimmune thyroid conditions
Maintenance dose55-100 ug/day (varies by baseline status)
DurationMinimum 3 months for anti-TPO response; 6-12 months for full assessment
Upper limit400 ug/day (includes dietary intake)
Dietary sourcesBrazil nuts (1-2 nuts = ~100 ug; highly variable by soil), seafood, organ meats

Monitoring#

Serum selenium: Baseline and at 3 months. Target range 100-130 ng/mL. Below 70 ng/mL indicates deficiency; above 150 ng/mL increases toxicity risk.

Anti-TPO antibodies: For Hashimoto's Thyroiditis—check at baseline, 3 months, 6 months. copper (Cu)/selenium (Se) ratio: For cardiovascular risk assessment. Elevated ratio warrants selenium repletion before copper reduction.

Selenosis signs: Monitor for garlic breath, brittle nails/hair, GI disturbance, peripheral neuropathy.

Contraindications and Risks#

Toxicity above 400 ug/day: Selenosis presents as hair loss, nail brittleness, garlic-odor breath, fatigue, irritability, and peripheral neuropathy. Chronic excess may increase type 2 diabetes risk (SELECT trial signal).

Selenium-replete populations: No benefit demonstrated in individuals with adequate baseline selenium (>106 ng/mL for prostate cancer; >100 ng/mL generally). The SELECT trial's null result likely reflects supplementation of already-replete American men.

U-shaped dose-response: Both deficiency and excess associate with adverse outcomes. "More is not better" applies strongly to selenium. Drug interactions: May potentiate anticoagulant effects; may interact with statins and cisplatin.

Connections#

Entities: Selenium, Copper

Concepts: selenoprotein-synthesis, Nutritional Immunity (Metal Sequestration), Oxidative Stress, Thyroid Autoimmunity

Related interventions: Vitamin D Supplementation (synergistic with selenium (Se) for Hashimoto's), Iron Management (thyroid function requires both selenium and iron (Fe))

Signatures: Hashimoto's Thyroiditis, Graves' Disease, Cardiovascular Disease

> Educational content, not medical advice. This page describes mechanisms by which the intervention interacts with the microbiome and metal ecology. It is not a treatment recommendation.

Clinical decisions about any intervention should be made with a qualified healthcare practitioner who knows your individual history.

Knowledge graph

Article network

Researcher discussion

Connect the evidence

Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.

0 posts

No discussion yet. Start with a precise question or a source-backed observation.

Transparent record

Activity and accepted changes

Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.

4 events
  1. published revision

    massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers

    WikiBiome Deploy Bot · +26 −26

    Inspect exact Git diff ↗
  2. published revision

    pre-overnight checkpoint 2026-04-18

    WikiBiome Deploy Bot · +5 −3

    Inspect exact Git diff ↗
  3. published revision

    Adversarial audit fixes: confidence downgrades, disclaimers, STOP safety, entity cleanup

    WikiBiome Deploy Bot · +7 −0

    Inspect exact Git diff ↗
  4. published revision

    WikiBiome v2 migration: signature pages + safety fixes + gap analysis

    WikiBiome Deploy Bot · +111 −0

    Inspect exact Git diff ↗
Continue exploring

Every article is a doorway.

Generated from the WikiBiome Markdown vault and reconciled against its source registry.

0 references · 7 backlinks · 6 indexed topics